Acute Liver Injury after Three Doses of Nitrofurantoin
DOI:
https://doi.org/10.17140/IMOJ-5-115Keywords:
Nitrofurantoin, Urinary tract infection, Idiosyncratic drug induced liver injury, Acute reversible hepatotoxicity, Flu-like illness, Elevated transaminasesAbstract
A 56-year-old lady presented to the hospital with 2-day history of flu like symptoms. These had begun within a few hours after starting Nitrofurantoin for urinary tract infection that was prescribed by her primary care doctor. Blood tests upon admission revealed elevated aminotransferase levels with normal bilirubin levels. The medication was stopped, and other causes of hepatitis were investigated. Nitrofurantoin induced idiosyncratic drug-induced liver injury (IDILI) was confirmed by excluding all other causes. Patient’s symptoms and liver enzymes improved the next day and she was discharged. A follow-up on the laboratory's nine-days later revealed liver enzymes almost back to normal.
References
Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, et al. ACG clinical guideline: The diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gas-troenterol. 2014; 109(7): 950-966. doi: 10.1038/ajg.2014.131
Sakaan SA, Twilla JD, Usery JB, Winton JC, Self TH. Nitrofuran-toin-induced hepatotoxicity: A rare yet serious complication. South Med J. 2014; 107: 107-113. doi: 10.1097/SMJ.0000000000000059
Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-in-duced liver injuty. Semin Liver Dis. 2009; 29: 337-347. doi: 10.1055/ s-0029-1240002
Wei G, Bergquist A, Broome U, Lindgren S, Wallerstedt S, Almer S, et al. Acute liver failure in Sweden: Etiology and outcome. J Intern Med. 2007; 262: 393-401. doi: 10.1111/j.1365-2796.2007.01818.x
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Submit your article to this journal | https://openventio.org/submit-manuscript/ 4 Pujar T et al Group. Drug-induced acute liver failure: Results of a U.S. multi-center, prospective study, prospective study. Hepatology. 2010; 52: 2065-2076. doi: 10.1002/hep.23937
Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Ice-land. Gastroentorology. 2013; 144: 1419-1425. doi: 10.1053/j.gas-tro.2013.02.006
Chalasani N, Bonkovosky HL, Fontana R, Lee W, Stolz A, Tal-walkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology. 2015; 148: 1340-1352.. doi: 10.1053/j.gastro.2015.03.006
Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis. 2007; 11: 459-475, v. doi: 10.1016/j. cld.2007.06.001
Uetrecht J. Immune-mediated adverse drug reactions. Chem Res Toxicol. 2009; 22: 24-34. doi: 10.1021/tx800389u
Hamilton LA, Collins-Yoder A, Collins RE. Drug-induced liver injury. AACN Adv Crit Care. 2016; 4: 430-440. doi: 10.4037/aac-nacc2016953
Kapral N, Saxena R, Sule AA, Markle B. Nitrofurantoin: Friend or foe? BMJ Case Rep. 2018; 388-401. doi: 10.1136/bcr-2018-
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Internal Medicine (IMOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.